0001209191-22-028660.txt : 20220512 0001209191-22-028660.hdr.sgml : 20220512 20220512191702 ACCESSION NUMBER: 0001209191-22-028660 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220504 FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bradrick Brittany CENTRAL INDEX KEY: 0001904176 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 22919617 MAIL ADDRESS: STREET 1: C/O DERMATA THERAPEUTICS, INC. STREET 2: 3525 DEL MAR HEIGHTS RD., #322 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-05-04 1 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001904176 Bradrick Brittany 11500 S. EASTERN AVE., SUITE 220 HENDERSON NV 89052 1 0 0 0 /s/ Keith M. McGahan, attorney-in-fact for Brittany K. Bradrick 2022-05-12 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY
AUTHORIZATION

I hereby authorize Thomas J. Riga and Keith M. McGahan, acting singly,
to sign and file on my behalf any and all forms required by the Securities
and Exchange Commission pursuant to Section 16 of the Securities Exchange
Act of 1934 (the "Exchange Act") relating to the reporting of beneficial
ownership of equity securities of Spectrum Pharmaceuticals, Inc.,
a Delaware corporation (the "Company"), and of changes in such beneficial
ownership, together with any and all amendments thereto.  This
authorization shall be effective on and after the date set forth
below and shall continue in effect until I am no longer required
to file such forms, unless earlier revoked by me in writing.

I acknowledge that the persons authorized hereunder are not assuming,
nor is the Company assuming, any of my responsibilities to comply with
Section 16 of the Exchange Act.

Dated as of this 25th day of April 2022.

/s/ Brittany K. Bradrick